Pfizer Inc (NYSE:PFE) maintains global operations across medicines and vaccines, delivering consistent earnings, operational ...

Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company"), a developer ...

Americans are not paying high prices because of other western countries. Pharmaceutical companies are to blame ...

The agreement will lower the cost of certain drugs for asthma, some cancers, HIV and Type 2 diabetes, among other conditions.

This article will be updated throughout the day, so check back often for more daily updates. The Vanguard S&P 500 ETF (NYSEMKT: VOO) is up 0.5% premarket on some surprisingly good economic news. The U ...

In 2025, Anthropic will grow from $1 billion to $9 billion in ARR (annual recurring revenue). OpenAI, meanwhile, will go from ...

President Donald Trump announced nine of the largest drugmakers in the U.S. and Europe agreed to voluntarily sell their ...

Manufactured by Connecticut-based biopharmaceutical company MannKind Corporation, Afrezza was first launched in the United ...

How Players Are Shaping Growth. EINPresswire/ -- The Complete Nutrition Products market is dominated by a mix of global nutrition leaders and regional innovators. Companies are focusing on ...

Continued revenue growth and commercial projects fuel Telescope’s successful intelligent automation and advanced chemical manufacturing portfolio Vancouver, British Columbia–(Newsfile Corp.

Telescope Innovations Corp ( ($TSE:TELI) ) has shared an update. Telescope Innovations reported fiscal 2025 revenues of $5.8 million, up from $4.4 ...

The "Motion Sickness Treatment Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering.